SRX-5000

N/A

Report date: 2025/06/11 11:11:04
NME

Base Information

Drug NameSRX-5000
Drug Alias Namecombination therapy (SignalRx)SF-5000SRX-5000
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsPI3-kinase class I inhibitors
TargetsPI3-kinase class I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignalrx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSignalrx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A